Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
NPJ Genomic Medicine
|
January 15, 2026
Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE
Giampaolo Trivellin, Víctor Sánchez-Gaya, Alexia Grasso, et al.
Frontiers in Endocrinology
|
September 15, 2023
The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the <i>aryl hydrocarbon receptor interacting protein</i> (AIP) gene
Laurent Vroonen, Albert Beckers, Severine Camby, et al.
Endocrine-Related Cancer
|
March 15, 2018
Pheochromocytomas and pituitary adenomas in three patients with <i>MAX</i> exon deletions
Adrian F Daly, Emilie Castermans, Lindsey Oudijk, et al.
Endocrine-Related Cancer
|
March 11, 2016
Screening for GPR101 defects in pediatric pituitary corticotropinomas
Giampaolo Trivellin, Ricardo R Correa, Maria Batsis, et al.
European Journal of Endocrinology
|
June 6, 2019
Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma
Eva C Coopmans, Sebastiaan W F van Meyel, Kay J Pieterman, et al.
Endocrine-Related Cancer
|
April 1, 2011
Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation
Chiara Villa, Maria Stefania Lagonigro, Flavia Magri, et al.
European Journal of Endocrinology
|
August 25, 2012
Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients
Laurent Vroonen, Marie-Lise Jaffrain-Rea, Patrick Petrossians, et al.
American Journal of Human Genetics
|
February 24, 2022
Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism
Martin Franke, Adrian F Daly, Leonor Palmeira, et al.
AACE Clinical Case Reports
|
May 23, 2022
Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor-Interacting Protein-mutated Pediatric Somatotropinoma
Selveta Sanne van Santen, Adrian F Daly, Michael Buchfelder, et al.
Endocrine-Related Cancer
|
December 17, 2015
GHRH excess and blockade in X-LAG syndrome
Adrian F Daly, Philippe A Lysy, Céline Desfilles, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
NPJ Genomic Medicine
|
January 15, 2026
Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE
Giampaolo Trivellin, Víctor Sánchez-Gaya, Alexia Grasso, et al.
Frontiers in Endocrinology
|
September 15, 2023
The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the <i>aryl hydrocarbon receptor interacting protein</i> (AIP) gene
Laurent Vroonen, Albert Beckers, Severine Camby, et al.
Endocrine-Related Cancer
|
March 15, 2018
Pheochromocytomas and pituitary adenomas in three patients with <i>MAX</i> exon deletions
Adrian F Daly, Emilie Castermans, Lindsey Oudijk, et al.
Endocrine-Related Cancer
|
March 11, 2016
Screening for GPR101 defects in pediatric pituitary corticotropinomas
Giampaolo Trivellin, Ricardo R Correa, Maria Batsis, et al.
European Journal of Endocrinology
|
June 6, 2019
Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma
Eva C Coopmans, Sebastiaan W F van Meyel, Kay J Pieterman, et al.
Endocrine-Related Cancer
|
April 1, 2011
Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation
Chiara Villa, Maria Stefania Lagonigro, Flavia Magri, et al.
European Journal of Endocrinology
|
August 25, 2012
Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients
Laurent Vroonen, Marie-Lise Jaffrain-Rea, Patrick Petrossians, et al.
American Journal of Human Genetics
|
February 24, 2022
Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism
Martin Franke, Adrian F Daly, Leonor Palmeira, et al.
AACE Clinical Case Reports
|
May 23, 2022
Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor-Interacting Protein-mutated Pediatric Somatotropinoma
Selveta Sanne van Santen, Adrian F Daly, Michael Buchfelder, et al.
Endocrine-Related Cancer
|
December 17, 2015
GHRH excess and blockade in X-LAG syndrome
Adrian F Daly, Philippe A Lysy, Céline Desfilles, et al.
Page
of 14